\(
\def\WIPO{World Intellectual Property Organisation}
\)
Formatos
| Formato | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Detalles
Título
Not all pharma IP law is transferable.
Tipo de elemento
Journal article
Descripción
GB 139 May 2010, p. 96; [28] cm
ISSN
2044-7175
Número de llamada alternativo
GB 139
Resúmen
The battle for supremacy between Europe and the US in the fields of pharmaceutical R&D and innovation has pointlessly flared up once again. A recently published survey by international intellectual property specialists Marks & Clerk indicates that the US IP system is viewed as being more favourable to innovation and that President Obama's recently passed healthcare reforms are proving to be increasingly palatable for big pharma.
Publicado
London, England: Informa, U.K. 2010.
Lengua(s)
eng
El registro aparece en